Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

The risk of stroke increases with growing difference between resting and maximal exercise systolic blood pressure (SBP), independent of BP at rest, according to a study. This suggests that an exaggerated BP response to physical exercise is independently predictive of stroke.

Exaggerated BP response to exercise predicts stroke

Abnormal STE myocardial function prevalent in women with HELLP syndrome history

The rate of abnormal speckle-tracking echocardiography (STE) myocardial function is high during the first years following a pregnancy complicated by haemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome, regardless of whether there was concomitant pre-eclampsia (PE), reveals a study.

Abnormal STE myocardial function prevalent in women with HELLP syndrome history

Smartphone app helps improve physical function in peripheral artery disease

27 Sep 2021 bởi

TrackPAD, a mobile phone health app designed specifically for patients with peripheral artery disease (PAD), leads to better exercise outcomes, improving their 6-minute walking distance (6MWD) and disease-related quality of life (QoL), according to a recent study.

Smartphone app helps improve physical function in peripheral artery disease

Aggressive hydration averts contrast-induced AKI in STEMI patients undergoing PCI

Perioperative aggressive hydration appears to be better than general hydration at preventing contrast-induced acute kidney injury (AKI) among patients with myocardial infarction with ST-segment elevation (STEMI) undergoing primary percutaneous coronary intervention (PCI), a study has found.

Aggressive hydration averts contrast-induced AKI in STEMI patients undergoing PCI

26 Sep 2021

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

There appears to be substantial long-term risks and consequences of anticoagulant-related major bleeding in patients with a first unprovoked venous thromboembolism (VTE), suggests a recent study.

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

Add-on bempedoic acid may benefit patients with statin intolerance

Bempedoic acid may be a boon to patients with full statin intolerance, as its addition can lessen the need for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and serve as a less expensive alternative to established oral lipid-lowering medications, according to a study.

Add-on bempedoic acid may benefit patients with statin intolerance

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

25 Sep 2021 bởi

The large, phase III FIGARO-DKD trial strengthen the evidence on cardiovascular benefit (CV) of the nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone, in addition to its renal benefit, across a wide spectrum of patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

25 Sep 2021

Coding changes for type 2, 3–5 MI tied to decrease in hospitalizations for new ICD-10 type 1 MI

25 Sep 2021

The introduction of the International Classification of Disease (ICD)-10 codes for type 2 and types 3–5 myocardial infarction (MI) leads to a reduction in hospitalizations for ICD-10 codes now attributed to type 1 MI and correlates with changes in the observed characteristics and treatment patterns of these patients, according to a study.

Coding changes for type 2, 3–5 MI tied to decrease in hospitalizations for new ICD-10 type 1 MI

25 Sep 2021

New strategies needed for low medication persistence in severe hypertension, says study

New pharmacological and nonpharmacological management strategies should be implemented for people with severe hypertension, suggest the results of a study involving a large primary prevention population in France.

New strategies needed for low medication persistence in severe hypertension, says study

Renal denervation safe, effective in lowering office SBP

Renal denervation (RDN) can safely and effectively reduce office systolic blood pressure (OSBP) for up to 36 months after the procedure, a recent South Korea study has found.

Renal denervation safe, effective in lowering office SBP